Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI-1910 |
Trade Name | |
Synonyms | BI1910|BI 1910 |
Drug Descriptions |
BI-1910 is an agonistic antibody that targets TNFR2, potentially leading to activation of an anti-tumor immune response (J Immunother Cancer 2023;11). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI-1910 | BI-1910 | 0 | 1 |
BI-1910 + Pembrolizumab | BI-1910 Pembrolizumab | 0 | 1 |